Evidence map›Paper›PMID 33454759›Full record

ArticleJournal of radiation research2021

Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group.

Hikaru Kubota, Naoki Nakamura, Naoto Shikama, Ayako Tonari, Hitoshi Wada, Hideyuki Harada, Hisayasu Nagakura, Joichi Heianna, Kei Ito, Miwako Nozaki and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 1 country.

Hikaru KubotaDepartment of Radiation Oncology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture 650-0017, Japan.
Naoki NakamuraDepartment of Radiation Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao Kawasaki City, Kanagawa prefecture 216-8511, Japan.
Naoto ShikamaDepartment of Radiation Oncology, Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan.
Ayako TonariDepartment of Radiation Oncology, Kyorin University Hospital, 6-20-2 Shinkawa, Mitaka-shi, Tokyo 181-8611, Japan.
Hitoshi WadaDepartment of Radiation Oncology, Southern TOHOKU Proton Therapy Center, 172-7, Yatsuyamada,Koriyama,Fukushima 963-8563, Japan.
Hideyuki HaradaDivision of Radiation Therapy, Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture 411-8777, Japan.
Hisayasu NagakuraDepartment of Radiology, KKR Sapporo Medical Center, 6-3-40 Hiragishi-1, Toyohira-ku, Sapporo 062-0931, Japan.
Joichi HeiannaDepartment of Radiation Oncology, Ryukyu University Hospital.
Kei ItoDepartment of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan.
Miwako NozakiDepartment of Radiation Oncology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minamikoshigaya, Koshigaya, Saitama, Japan.
Masao TagoDepartment of Radiology, Teikyo University Mizonokuchi Hospital, 3-8-3, Mizokuchi, Takatsu-ku, Kawasaki city, Kanagawa pref., Japan.
Masato FushikiDepartment of Radiation Oncology, Nagahama City Hospital, 313 Oinuicho, Nagahama, Shiga 526-8580, Japan.
Nobue UchidaDepartment of Radiation Oncology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-ku, Tokyo 108-0073, Japan.
Norio ArakiDepartment of Radiation Oncology, Kyoto Medical Center, 1-1 Fukakusamukaihatacho, Fushimi-ku, Kyoto-shi, Kyoto 612-8555, Japan.
Shuhei SekiiDepartment of Radiation Oncology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture 650-0017, Japan.
Takashi KosugiDepartment of Radiation Oncology, Fujieda Municipal General Hospital, 4-1-11 Surugadai, Fujieda City, Shizuoka Prefecture 426-8677, Japan.
Takeo TakahashiDepartment of Radiation Oncology, Saitama Medical University Saitama Medical Center, 1981 kamoda,kawagoeshi, saitama 350-8550, Japan.
Terufumi KawamotoDepartment of Radiation Oncology, Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan.
Tetsuo SaitoDepartment of Radiation Oncology, Arao Municipal Hospital, 2600 Arao, Arao City, Kumamoto 864-0041, Japan.
Kazunari YamadaDepartment of Radiation Oncology, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu, Shizuoka 433-8558, Japan.
Juntendo University Hospital · JPKobe University Hospital · JPDokkyo Medical University Saitama Medical Center · JPFujieda Municipal General Hospital · JPKyorin University Hospital · JPKyoto Medical Center · JPNagahama City Hospital · JPNTT Medical Center · JPSaiseikai Central Hospital · JPSaitama Medical University · JPSeirei Mikatabara General Hospital · JPShizuoka Cancer Center · JPSouthern Tohoku General Hospital · JPSt. Marianna University School of Medicine · JPTeikyo University · JPTokyo Metropolitan Komagome Hospital · JPUniversity of the Ryukyus University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence regarding postoperative radiation therapy (PORT) for metastases to the long bones is lacking. Characterizing the current practice patterns and identifying factors that influence dose-fractionation schedules are essential for future clinical trials. An internet-based survey of the palliative RT subgroup of the Japanese Radiation Oncology Study Group was performed in 2017 to collect data regarding PORT prescription practices and dose-fractionation schedules. Responders were also asked to recommend dose-fractionation schedules for four hypothetical cases that involved a patient with impending pathological fractures and one of four clinical features (poor prognosis, solitary metastasis, radio-resistant primary tumor or expected long-term survival). Responders were asked to indicate their preferred irradiation fields and the reasons for the dose fractionation schedule they chose. Responses were obtained from 89 radiation oncologists (67 institutions and 151 RT plans) who used 22 dose-fractionation schedules, with the most commonly used and recommended schedule being 30 Gy in 10 fractions. Local control was the most common reason for preferring longer-course RT. High-dose fractionated schedules were preferred for oligometastasis, and low-dose regimens were preferred for patients with a poor prognosis; however, single-fraction RT was not preferred. Most respondents recommended targeting the entire orthopedic prosthesis. These results indicated that PORT using 30 Gy in 10 fractions to the entire orthopedic prosthesis is preferred in current Japanese practice and that single-fraction RT was not preferred. Oligometastasis and poor prognosis influenced the selection of high- or low-dose regimens.

Indexed as

Practice Patterns, Physicians'Radiation OncologySurveys and QuestionnairesAdultAgedBone NeoplasmsDose Fractionation, RadiationHumansJapanMiddle Agedbone metastaseslong bonesoligometastasispatterns of practicepostoperative radiation therapy

Identifiers

PMID33454759
PMCPMC7948830
OpenAlexW3124631028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.